What is Increlex (mecasermin)?
Increlex is a brand of mecasermin, a human insulin-like growth factor-1 (IGF-1) used to treat certain growth problems related to low IGF-1 signaling. [1]
What conditions does Increlex treat?
Increlex is used for specific pediatric growth disorders where IGF-1 is involved, including cases of severe primary IGF-1 deficiency and growth failure in children with severe growth hormone (GH) insensitivity (Laron syndrome). [1]
How does Increlex work?
Mecasermin (IGF-1) is intended to replace or supplement IGF-1 activity so children can grow when their bodies cannot generate enough functional IGF-1 signaling. [1]
How is Increlex taken (and what dosing is like)?
Increlex is administered by injection. The prescribing approach typically includes timing relative to meals to reduce risk of low blood sugar, since IGF-1 can affect glucose metabolism. [1]
What side effects do patients and caregivers watch for?
A key safety concern with Increlex is hypoglycemia (low blood sugar). Other commonly discussed effects can include injection-site reactions and other symptoms related to changes in metabolism. [1]
Does Increlex have generic or biosimilar competition?
For information on patents and exclusivity (and whether competition is expected), DrugPatentWatch.com tracks medication IP status and related developments. You can check Increlex’s page here: [2]
What does the patent/exclusivity landscape look like?
If you’re looking for when exclusivity or patents expire, DrugPatentWatch.com is one of the sources that compiles those timelines and legal milestones for drugs like Increlex. [2]
Looking for the most relevant “Increlex” details—what do you need?
If you tell me which angle you care about (cost/availability, dosing schedule, side effects, or patents/when generics could arrive), I can narrow the answer to that exact need.
Sources
[1] https://www.drugs.com/increlex.html
[2] https://www.drugpatentwatch.com/